Genomics of high-grade neuroendocrine neoplasms: well-differentiated neuroendocrine tumor with high-grade features (G3 NET) and neuroendocrine carcinomas …

S Uccella, S La Rosa, J Metovic, D Marchiori… - Endocrine …, 2021 - Springer
High-grade neuroendocrine neoplasms (HG-NENs) are clinically aggressive diseases, the
classification of which has recently been redefined. They now include both poorly …

SWI/SNF-deficient sinonasal carcinomas

A Agaimy - Advances in Anatomic Pathology, 2023 - journals.lww.com
The classification of poorly differentiated sinonasal carcinomas and their nonepithelial
mimics has experienced tremendous developments during the last 2 decades. These recent …

IDH2 R172 mutations across poorly differentiated sinonasal tract malignancies: forty molecularly homogenous and histologically variable cases with favorable …

S Glöss, P Jurmeister, A Thieme… - The American journal …, 2021 - journals.lww.com
IDH2 R172 mutations occur in sinonasal undifferentiated carcinoma (SNUC), large-cell
neuroendocrine carcinoma (LCNEC), sinonasal adenocarcinomas, and olfactory …

Proceedings of the north American society of head and neck pathology, Los Angeles, CA, march 20, 2022: SWI/SNF-deficient sinonasal neoplasms: an overview

A Agaimy - Head and Neck Pathology, 2022 - Springer
The pathology of poorly differentiated sinonasal malignancies has been the subject of
extensive studies during the last decade, which resulted into significant developments in the …

SWI/SNF complex-deficient undifferentiated carcinoma of the pancreas: clinicopathologic and genomic analysis

A Yavas, K Ozcan, NV Adsay, S Balci, ZC Tarcan… - Modern pathology, 2024 - Elsevier
Inactivating alterations in the SWItch/Sucrose NonFermentable (SWI/SNF) Chromatin
Remodeling Complex subunits have been described in multiple tumor types. Recent studies …

SWI/SNF-deficient head and neck neoplasms: An overview

A Agaimy, JA Bishop - Seminars in diagnostic pathology, 2021 - Elsevier
With wide-spread use of next generation sequencing tools in surgical pathology, a variety of
neoplasms have been increasingly recognized to be associated with specific recurrent …

SMARCB1 (INI-1)-deficient sinonasal carcinoma: a systematic review and pooled analysis of treatment outcomes

VHF Lee, RKY Tsang, AWI Lo, SY Chan, JCK Chung… - Cancers, 2022 - mdpi.com
Simple Summary SMARCB1 (INI-1)-deficient sinonasal carcinoma is a rare but locally
aggressive malignancy which usually presents very late with invasion into the orbits and …

Molecular biomarkers in sinonasal cancers: new frontiers in diagnosis and treatment

M Turri-Zanoni, G Gravante, P Castelnuovo - Current Oncology Reports, 2022 - Springer
Abstract Purpose of Review Sinonasal tumors are rare and heterogeneous diseases which
pose challenges in diagnosis and treatment. Despite significant progress made in surgical …

Molecular basis and rationale for the use of targeted agents and immunotherapy in sinonasal cancers

A Esposito, E Stucchi, M Baronchelli… - Journal of Clinical …, 2022 - mdpi.com
Despite the progress of surgery, radiotherapy, and neoadjuvant chemotherapy, the
prognosis for advanced sinonasal cancers (SNCs) remains poor. In the era of precision …

FGFR1/2/3‐rearranged carcinoma of the head and neck: expanded histological spectrum crossing path with high‐risk HPV in the sinonasal tract

YH Chu, K Mullaney, SE DiNapoli, MA Cohen… - …, 2024 - Wiley Online Library
Aims Oncogenic FGFR1/2/3 rearrangements are found in various cancers. Reported cases
in head and neck (HN) are mainly squamous cell carcinomas (SCCs) with FGFR3:: TACC3 …